Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.41 |
| ▸ | PARP14 | Q460N5 | 11/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | MAP3K11 | Q16584 | 2/20 | 0.38 |
| ▸ | MAP3K9 | P80192 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.38 |
| ▸ | CDK4 | P11802 | 1/20 | 0.38 |
| ▸ | CCND1 | P24385 | 1/20 | 0.38 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
| ▸ | CAMK2B | Q13554 | 1/20 | 0.38 |
| ▸ | CAMK2G | Q13555 | 1/20 | 0.38 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.38 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30333067 | 0.86 | PARP14 (0.47) | PARP14MAP3K11KIF11 | |
| SCHEMBL1495149 | 0.86 | PARP14 (0.47) | PARP14MAP3K11KIF11 | |
| SCHEMBL27153794 | 0.82 | PARP14 (0.42) | AHRPARP14IDO1TDO2MAP3K11 | |
| SCHEMBL30022409 | 0.81 | GABRP (0.44) | PARP14MAP3K11MAP3K9KIF11 | |
| SCHEMBL29177820 | 0.80 | GABRP (0.43) | PARP14MAP3K11MAP3K9KIF11 | |
| SCHEMBL30103674 | 0.78 | PARP14 (0.40) | PARP14TDO2MAP3K11MAP3K9CCNE2 | |
| SCHEMBL30022058 | 0.77 | PARP14 (0.40) | PARP14MAP3K11MAP3K9KIF11 | |
| SCHEMBL589279 | 0.75 | PARP14 (0.39) | PARP14MAP3K11MAP3K9KIF11CCNE2 | |
| SCHEMBL29177859 | 0.75 | PARP14 (0.52) | PARP14 | |
| SCHEMBL16950109 | 0.75 | GABRP (0.41) | PARP14MAP3K11MAP3K9KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240114789-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-04-04 | — | — | US | disclosed |
| CN-117098766-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2023-11-21 | — | — | CN | disclosed |
| WO-2022223846-A1 | ORAGNIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240114789-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, ORC3, C1R | AHR 907/4885PARP14 4018/4885IDO1 1417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.